BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
Generic: BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
Alembic Pharmaceuticals LimitedManufacturer
OPHTHALMICRoute
BRIMONIDINE TARTRATEActive Substance
2023-08-25Original Approval
BRIMONIDINE TARTRATE AND TIMOLOL MALEATE is FDA application ANDA215230, sponsored by ALEMBIC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
BLINDNESS
4 reports
2
EYE DISORDER
4 reports
3
BLINDNESS UNILATERAL
3 reports
4
OCULAR HYPERAEMIA
3 reports
5
DEATH
2 reports
6
DRY EYE
2 reports
7
EYE PAIN
2 reports
8
GLAUCOMA
2 reports
9
OPTIC NERVE INJURY
2 reports
10
PRODUCT SUBSTITUTION ISSUE
2 reports